![IDF and the Medicines Patent Pool welcome inclusion of SGLT2 inhibitors to the WHO Essential Medicines List - International Diabetes Federation IDF and the Medicines Patent Pool welcome inclusion of SGLT2 inhibitors to the WHO Essential Medicines List - International Diabetes Federation](https://idf.org/media/uploads/2021/10/Oral-medicines-1132x700.png)
IDF and the Medicines Patent Pool welcome inclusion of SGLT2 inhibitors to the WHO Essential Medicines List - International Diabetes Federation
![Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study - Grymonprez - 2023 - British Journal of Clinical Pharmacology - Wiley Online Library Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study - Grymonprez - 2023 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/4eef6a0d-9f73-43df-a3a3-eddc1584a88a/bcp15582-fig-0002-m.jpg)
Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study - Grymonprez - 2023 - British Journal of Clinical Pharmacology - Wiley Online Library
![Estimating benefits of using on-demand oral prep by MSM: a comparative modeling study of the US and Thailand - eClinicalMedicine Estimating benefits of using on-demand oral prep by MSM: a comparative modeling study of the US and Thailand - eClinicalMedicine](https://www.thelancet.com/cms/asset/271a2cd3-6011-4ec7-991c-e878548e894a/gr1.jpg)